A systematic literature review of treatment costs for patients with Acute Myocardial Infarction

Objective: To analyze the costs treatment for patients with Acute Myocardial Infarction (AMI) over the period from 2000 to 2016. Materials and methods: Systematic review of the literature on the costs of treatment for patients with Acute Myocardial Infarction in the period 2000-2016. We selected 30 scientific articles from the database Scielo, Medline, Redalyc, Springer Medizin and Lilacs, which met the inclusion criteria: articles published in Spanish, Portuguese or English from 2000 to 2016. To restrict the search of articles, we use the health descriptors: costs, myocardial infarction and cardiovascular, combining them with the Boolean operators "AND", "OR" and "NOT". Of which, a sample of 11 articles was selected. Results: It was evidenced that a high percentage (63.6%) came from the Scielo database. According to the country of origin of the articles, it was identified that the highest percentage (36.4%) came from Colombia. Concerning the direct and indirect costs of patients with Acute Myocardial Infarction (AMI) from an international perspective, the total estimated cost for Acute Coronary Syndrome (ACS) in 2011, including direct and indirect costs, is $1.26 million (US dollars are used throughout). In Colombia, the average cost of a case of AMI during the first five years after diagnosis is USD $8,786.9. Ambulatory management costs represent 54%. Conclusion: The costs of people with Acute Myocardial Infarction in both ambits, the international and national (Colombia) are significantly attributable by surgical interventions, treatment, hospital stay and post-diagnostic outpatient management.